Minsun Kang

Dr. Minsun Kang

Gachon University Gil Medical Center Artificial Intelligence and Big-Data Convergence Center
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
Wonjun JiWonjun Ji
Wonjun Ji
KHKyungmin Huh
Kyungmin Huh
MKMinsun Kang
Minsun Kang
JHJinwook Hong
Jinwook Hong
GBGi Hwan Bae
Gi Hwan Bae
JJJaehun Jung
Jaehun Jung
Ji W, et al. J Korean Med Sci. 2020 May;35(25):e237. https://doi.org/10.3346/jkms.2020.35.e237

JYJeonggyo Yoon
Jeonggyo Yoon
MKMinsun Kang
Minsun Kang
JJJaehun Jung
Jaehun Jung
MJMin Jae Ju
Min Jae Ju
SJSung Hwan Jeong
Sung Hwan Jeong
Yoon-Hyeong ChoiYoon-Hyeong Choi
Yoon-Hyeong Choi
Humidifier disinfectant (HD) is a household biocidal product used in humidifier water tanks to prevent the growth of microorganisms. In 2011, a series of lung injury cases of unknown causes emerged in children and pregnant women who had used HD in Korea. This study investigated changes in the nationwide number of cases of humidifier disinfectant-associated lung injury (HDLI) in concordance with nationwide HD consumption using data covering the entire Korean population. More than 25 kinds of HD products were sold between 1994 and 2011. The number of diagnosed HDLI, assessed by S27.3 (other injuries of lungs) of the Korea National Health Insurance Service (NHIS) data, sharply increased by 2005, subsequently decreased after 2005, and almost disappeared after 2011 in concordance with the annual number of HD sales. The number of self-reported HDLIs, assessed using data from all suspected HDLI cases registered in the Korea Ministry of Environment, changed with the annual number of HD sales, with a delay pattern, potentially induced by the late awareness of lung injury diseases. The present study suggests that changes in the nationwide annual consumption of HD products were consistent with changes in the annual number of HDLI cases in Korea.

1 March 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
KHKyungmin Huh
Kyungmin Huh
Wonjun JiWonjun Ji
Wonjun Ji
MKMinsun Kang
Minsun Kang
JHJinwook Hong
Jinwook Hong
GBGi Hwan Bae
Gi Hwan Bae
JJJaehun Jung
Jaehun Jung
Concerns have been expressed that some drugs may increase susceptibility to SARS-CoV-2 infection. In contrast, other drugs have generated interest as potential therapeutic agents. All adults aged ≥18 years who were tested for COVID-19 were included. Exposure was defined as a prescription of study drugs which would have been continued until 7 days prior to test for COVID-19 or later. The outcome measures were the diagnosis of COVID-19 and severe COVID-19. Disease risk score matching and multiple logistic regression was used. Matched claims and testing results were available for 219,961 subjects, of whom 7,341 (3.34%) were diagnosed with COVID-19. Patients were matched to 36,705 controls, and the subset of 878 patients of severe COVID-19 also matched with 1,927 mild-to-moderate patients. Angiotensin receptor blockers were not associated with either the diagnosis of COVID-19 (adjusted OR [aOR], 1.02; 95% confidence interval [CI], 0.90–1.15) or severe disease (aOR, 1.11; 95% CI, 0.87–1.42). The use of hydroxychloroquine was not associated with a lower risk for COVID-19 (aOR, 0.94; 95% CI, 0.53–1.66) or severe disease (aOR, 3.51; 95% CI, 0.76–16.22). In this national claims data-based case-control study, no commonly prescribed medications were associated with risk of COVID-19 infection or COVID-19 severity.

29 June 2022 in Microbiology Spectrum
Verified
Journal Article
Open access
DSDong Hoon Shin
Dong Hoon Shin
hyung-sook Kimhyung-sook Kim
hyung-sook Kim
EHEunjeong Heo
Eunjeong Heo
MSMyoung-Jin Shin
Myoung-Jin Shin
NKNak-Hyun Kim
Nak-Hyun Kim
HKHong Bin Kim
Hong Bin Kim
Antimicrobial stewardship programs aimed to optimize antibiotic use are difficult to implement in limited-resource settings. Our study indicates that stepwise implementation of core antimicrobial stewardship program elements was effective in reducing antibiotic use in a tertiary care hospital despite the lack of sufficient manpower.

19 September 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
KHKyungmin Huh
Kyungmin Huh
MKMinsun Kang
Minsun Kang
JJJaehun Jung
Jaehun Jung
Background and Aims: An increased risk of aortic aneurysm and aortic dissection (AA/AD) has been reported with fluoroquinolone (FQ) use. However, recent studies suggested confounding factors by indication. This study aimed to investigate the risk of AA/AD associated with FQ use. Methods: This nationwide population-based study included adults aged ≥20 years who received a prescription of oral FQ or third-generation cephalosporins (3GC) during outpatient visits from 2005 to 2016. Data source was the National Health Insurance Service reimbursement database. The primary outcome was hospitalization or in-hospital death with a primary diagnosis of AA/AD. A self-controlled case series (SCCS) and Cox proportional hazards model were used. Self-controlled case series compared the incidence of the primary outcome in the risk period vs. the control periods. Results: A total of 954 308 patients (777 109 with FQ and 177 199 with 3GC use) were included. The incidence rate ratios for AA/AD between the risk period and the pre-risk period were higher in the 3GC group [11.000; 95% confidence interval (CI) 1.420–85.200] compared to the FQ group (2.000; 95% CI 0.970–4.124). The overall incidence of AA/AD among the patients who received FQ and 3GC was 5.40 and 8.47 per 100 000 person-years. There was no significant difference in the risk between the two groups (adjusted hazard ratio 0.752; 95% CI 0.515–1.100) in the inverse probability of treatment-weighted Cox proportional hazards model. Subgroup and sensitivity analysis showed consistent results. Conclusions: There was no significant difference in the risk of AA/AD in patients who were administered oral FQ compared to those administered 3GC. The study findings suggest that the use of FQ should not be deterred when clinically indicated.

14 December 2023 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
KHKyungmin Huh
Kyungmin Huh
MKMinsun Kang
Minsun Kang
YKYoung-Eun Kim
Young-Eun Kim
YCYoonkyung Choi
Yoonkyung Choi
SASoo Jeong An
Soo Jeong An
JJJaehun Jung
Jaehun Jung
Background: Solid organ transplant recipients (SOTRs) are at higher risk for severe infection. However, the risk for severe COVID-19 and vaccine effectiveness among SOTRs remain unclear. Methods: This retrospective study used a nationwide health care claims database and COVID-19 registry from the Republic of Korea (2020 to 2022). Adult SOTRs diagnosed with COVID-19 were matched with up to 4 non-SOTR COVID-19 patients by propensity score. Severe COVID-19 was defined as treatment with high-flow nasal cannulae, mechanical ventilation, or extracorporeal membrane oxygenation. Results: Among 6783 SOTRs with COVID-19, severe COVID-19 was reported with the highest rate in lung transplant recipients (13.16%), followed by the heart (6.30%), kidney (3.90%), and liver (2.40%). SOTRs had a higher risk of severe COVID-19 compared to non-SOTRs, and lung transplant recipients showed the highest risk (adjusted odds ratio, 18.14; 95% confidence interval [CI], 8.53–38.58). Vaccine effectiveness against severe disease among SOTRs was 47% (95% CI, 18%–65%), 64% (95% CI, 49%–75%), and 64% (95% CI, 29%–81%) for 2, 3, and 4 doses, respectively. Conclusions: SOTRs are at significantly higher risk for severe COVID-19 compared to non-SOTRs. Vaccination is effective in preventing the progression to severe COVID-19. Efforts should be made to improve vaccine uptake among SOTRs, while additional protective measures should be developed.